<DOC>
	<DOCNO>NCT00971061</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety Ahmed valve implant ( AVI ) Molteno single-plate implant ( MSPI ) eye refractory glaucoma follow-up period 24 month .</brief_summary>
	<brief_title>Ahmed Glaucoma Valve Single-Plate Molteno Implants Treatment Refractory Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<criteria>refractory glaucoma , define uncontrolled IOP despite maximal antiglaucoma medication , previously fail nonseton surgical treatment , combination thereof . age le 40 year visual acuity light perception lens opacity elevate IOP associate silicone oil previous glaucoma drainage device implantation eye previous cyclodestructive treatment increase risk endophthalmitis posterior segment disorder preexist ocular comorbidities .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Ahmed valve</keyword>
	<keyword>single-plate Molteno implant</keyword>
	<keyword>refractory glaucoma</keyword>
	<keyword>surgical treatment</keyword>
</DOC>